background
investig
potenti
proteom
fi
ngerprint
mass
spectrometr
serum
profi
ling
coupl
pattern
recognit
method
identifi
biomark
could
improv
diagnosi
tuberculosi
method
obtain
serum
proteom
profi
le
patient
activ
tuberculosi
control
surfaceenhanc
laser
desorpt
ionis
time
fl
ight
mass
spectrometri
supervis
machinelearn
approach
base
support
vector
machin
svm
use
obtain
classifi
er
distinguish
group
two
independ
test
set
use
kfold
cross
valid
random
sampl
svm
classifi
er
assess
classifi
er
relev
mass
peak
select
correl
analysi
assess
svm
test
diagnost
potenti
candid
biomark
identifi
ed
peptid
mass
fi
ngerprint
convent
immunoassay
svm
classifi
er
train
data
identifi
ed
quantit
immunoassay
peptid
refl
ect
infl
ammatori
state
also
quantit
neopterin
c
reactiv
protein
applic
svm
classifi
er
use
combin
valu
gave
diagnost
accuraci
tuberculosi
valid
second
prospect
collect
test
set
gave
similar
accuraci
use
whole
proteom
signatur
select
peak
use
combin
four
biomark
achiev
diagnost
accuraci
interpret
potenti
biomark
tuberculosi
identifi
ed
proteom
fi
ngerprint
pattern
recognit
plausibl
biolog
connect
diseas
could
use
develop
new
diagnost
test
latent
tuberculosi
present
third
world
popul
preval
activ
tuberculosi
mani
area
exceed
case
per
popul
global
epidem
fuell
synergi
hiv
found
african
patient
activ
tuberculosi
death
tuberculosi
prevent
earli
diagnosi
treatment
area
high
preval
sputum
smear
microscopi
often
avail
aff
ordabl
test
best
achiev
sensit
cultur
mycobacterium
tuberculosi
diagnost
gold
standard
sensit
specifi
c
case
smearposit
tuberculosi
take
week
yield
result
routin
use
countri
high
preval
tuberculosi
area
tuberculin
skin
test
often
insuffi
cientli
accur
aid
diagnosi
readili
distinguish
contain
infect
diseas
serolog
test
tuberculosi
focus
detect
mycobacteri
antigen
like
skin
test
confound
crossreact
nonpathogen
mycobacteria
previou
immunis
bcg
recent
develop
test
base
dna
amplifi
cation
interferon
releas
expens
need
particular
expertis
cheap
accur
rapid
diagnost
test
tuberculosi
immens
impact
control
diseas
exampl
test
yield
result
within
hour
sensit
similar
exist
test
sputum
microscopi
requir
two
clinic
visit
would
great
advanc
would
enabl
initi
treatment
singl
clinic
visit
proteom
fi
ngerprint
diagnost
concept
base
idea
diseas
state
sometim
associ
distinct
confi
gurat
circul
protein
biolog
complex
diseas
mean
individu
biomark
limit
diagnost
sensit
specifi
citi
analysi
combin
sever
biomark
er
possibl
enhanc
diagnost
accuraci
high
throughput
proteom
profi
ling
serum
revolutionis
recent
advanc
mass
spectrometri
surfaceenhanc
laser
desorpt
ionis
time
fl
ight
selditof
mass
spectrometri
applic
approach
base
machin
learn
problem
pattern
recognit
make
possibl
identifi
diagnost
combin
protein
diagnost
signatur
embed
within
profi
le
analysi
serum
proteom
fi
ngerprint
improv
diagnost
accuraci
cancer
infect
human
african
trypanosomiasi
approach
also
use
search
novel
biomark
sever
acut
respiratori
syndrom
intraamniot
infect
assess
potenti
proteom
fi
ngerprint
basi
diagnosi
pulmonari
tuberculosi
fi
rst
phase
studi
serum
sampl
obtain
patient
retrospect
confi
rmed
cultureposit
tuberculosi
bank
serum
sampl
collect
uganda
gambia
obtain
tb
specimen
bank
sampl
taken
time
fi
rst
present
design
outpati
clinic
initi
chemotherapi
tuberculosi
sampl
obtain
prospect
patient
present
tuberculosi
inpati
outpati
facil
st
georg
hospit
london
uk
restrict
mainli
patient
tuberculosi
present
typic
manifest
pulmonari
diseas
commonest
present
tuberculosi
adult
geograph
area
serum
sampl
control
collect
four
separ
site
st
georg
hospit
uk
angola
gambia
uganda
gambia
uganda
taken
specimen
bank
recruit
control
rang
infl
ammatori
condit
confi
rmed
standard
diagnost
criteria
clinic
featur
overlap
tuberculosi
exampl
includ
patient
sarcoidosi
frequent
includ
diff
erenti
diagnosi
pulmonari
tuberculosi
sever
respiratori
infect
repres
patient
nontubercul
destruct
pulmonari
patholog
allow
system
infl
ammatori
process
mimic
tuberculosi
recruit
patient
system
infect
patient
infl
ammatori
bowel
autoimmun
diseas
healthi
volunt
also
includ
among
control
distribut
case
control
intend
refl
ect
particular
popul
epidemiolog
set
encompass
broad
rang
symptomat
overlap
clinic
present
fi
rst
dataset
reli
heavili
archiv
sampl
subsequ
collect
second
dataset
entir
uk
valid
classifi
er
sampl
patient
tuberculosi
control
obtain
prospect
consecut
patient
predominantli
respiratori
symptom
attend
hammersmith
hospit
st
georg
hospit
london
serum
collect
within
day
fi
rst
present
initi
treatment
tuberculosi
patient
present
accid
emerg
depart
typic
case
tuberculosi
hospit
control
symptomat
underw
full
diagnost
assess
exclud
tuberculosi
dataset
fulli
inform
consent
obtain
everi
patient
accord
local
research
ethic
committe
polici
clinic
inform
archiv
link
anonymis
databas
serum
separ
ml
blood
centrifug
sampl
allow
clot
min
room
temperatur
steril
glass
tube
aliquot
frozen
c
within
h
collect
underw
two
freezethaw
cycl
mass
spectrum
analysi
sampl
appli
protein
chip
array
ciphergen
fremont
ca
usa
describ
previous
satur
solut
sinapin
acid
acetonitril
trifl
uoroacet
acid
appli
twice
spot
array
air
dri
applic
minimis
bia
serum
sampl
patient
tuberculosi
control
assay
chip
timeoffl
ight
spectra
gener
use
pbsii
mass
spectromet
ciphergen
freemont
ca
usa
laser
intens
high
mass
kda
detector
sensit
focu
mass
kda
spot
array
analys
posit
delta
seven
shot
per
posit
preced
two
warm
shot
laser
intens
everi
protein
chip
array
includ
univers
control
sampl
aliquot
singl
sampl
one
individu
store
c
group
spectra
tuberculosi
control
compris
sampl
run
diff
erent
occas
period
instrument
calibr
weekli
use
ciphergen
allinon
protein
peptid
calibr
identifi
peak
spectra
normalis
total
ion
current
mz
rang
baselin
subtract
patient
singl
spectrum
gener
laser
intens
select
minimis
deviat
total
ion
current
within
sd
mean
patient
describ
previous
biomark
wizard
version
use
identifi
correspond
peak
spectrum
peak
cluster
within
molecular
mass
signaltonois
ratio
set
fi
rst
pass
second
pass
identifi
protein
serum
incub
ice
min
denatur
buff
er
dilut
bind
buff
er
denatur
buff
er
dilut
mm
trishcl
ph
follow
min
incub
ice
sampl
appli
q
ceram
hyperd
spin
column
ciphergen
minut
preequilibr
fi
rst
tri
mm
ph
follow
bind
buff
er
kda
kda
biomark
elut
spin
column
elut
buff
er
mm
sodium
citrat
octyl
glucopyranosid
ph
select
enrich
confi
rmed
selditof
ms
biomark
resolv
onedimension
sdspage
nupag
bistri
invitrogen
carlsbad
ca
usa
stain
coomassi
blue
excis
gel
gel
piec
wash
three
time
mixtur
ammonium
bicarbon
mm
acetonitril
dehydr
acetonitril
dri
protein
subject
ingel
tryptic
digest
min
room
temperatur
addit
trypsin
acetonitril
ammonium
bicarbon
mm
follow
incub
ammonium
bicarbon
mm
h
peptid
mass
fi
ngerprint
digest
analys
matrixassist
laser
desorptionionis
timeoffl
ight
malditof
mass
spectrometri
use
acid
matrix
result
ingel
tryptic
digest
corrobor
tryptic
digest
passiv
elut
protein
gel
peptid
mass
fi
ngerprint
use
interrog
public
databas
mascot
search
engin
four
select
biomark
measur
region
protein
refer
laboratori
st
georg
hospit
commerci
avail
kit
valid
clinic
use
neopterin
measur
competit
elisa
kit
elitest
neopterin
brahm
aktiengesellschaft
hennigsdorf
germani
trituru
analys
diagnost
grifol
sa
barcelona
spain
rate
nephelemetri
use
measur
creactiv
protein
transthyretin
beckmann
immag
analys
beckman
coulter
fullerton
ca
usa
serum
amyloid
n
latex
saa
bn
ii
analys
dadebehr
marburg
germani
case
kit
use
accord
manufactur
instruct
antibodi
use
serum
amyloid
assay
detect
total
serum
amyloid
supervis
machin
learn
supervis
learn
algorithm
task
fi
nd
decis
function
capabl
assign
correct
label
set
inputoutput
pair
exampl
call
train
data
abil
decis
function
predict
correct
label
unseen
sampl
test
data
known
generalis
current
machin
learn
method
support
vector
machin
svm
aim
optimis
properti
webappendix
generalis
classifi
er
depend
set
paramet
model
must
chosen
optimis
perform
purpos
adopt
grid
search
strategi
rang
paramet
valu
use
test
use
crossvalid
use
two
crossvalid
scheme
kfold
crossvalid
train
set
randomli
split
k
group
equal
distribut
posit
neg
case
classifi
er
train
group
generalis
perform
valid
remain
group
process
repeat
k
time
time
hold
diff
erent
valid
subset
averag
repres
overal
generalis
second
scheme
kfold
crossvalid
test
data
fi
rst
randomli
split
train
test
set
kfold
crossvalid
perform
train
set
generalis
obtain
unseen
test
set
generalis
perform
classifi
er
assess
consid
number
correctli
classifi
ed
true
posit
tp
true
neg
tn
incorrectli
classifi
ed
fals
posit
fp
fals
neg
fn
case
test
set
sensit
se
defi
ned
condit
probabl
true
staphylococc
cellul
cerebr
neoplasia
cerebr
abscess
associ
infect
endocard
myasthenia
gravi
multipl
sclerosi
lumbar
disc
prolaps
arthriti
system
lupu
erythematosi
system
sclerosi
overlap
syndrom
see
onlin
webappendix
posit
setp
tpfn
specifi
citi
sp
condit
probabl
true
neg
sptn
tnfp
accuraci
ac
proport
correct
classifi
cation
ac
tptn
tpfptnfn
perform
posit
diagnost
likelihood
ratio
classifi
er
express
true
posit
rate
se
fals
posit
rate
plot
receiv
oper
curv
roc
space
creat
independ
train
test
set
similar
number
patient
tuberculosi
control
similar
represent
age
sex
set
use
set
evalu
generalis
perform
sever
supervis
machin
learn
method
singl
layer
perceptron
slp
multilay
perceptron
mlp
tree
classifi
er
svm
provid
robust
estim
generalis
capabl
classifi
er
tenfold
crossvalid
test
first
gener
train
test
set
random
sampl
without
replac
entir
dataset
train
test
set
tenfold
crossvalid
done
train
set
paramet
best
perform
chosen
svm
retrain
best
paramet
ten
subset
fi
nal
perform
assess
test
set
experi
roc
curv
smooth
sampl
averag
show
mean
curv
sd
valid
second
independ
test
set
classifi
er
refi
ned
train
entir
fi
rst
dataset
appli
second
set
use
pearson
correl
coeffi
cient
rank
peak
discriminatori
power
webappendix
use
test
statist
assess
signifi
canc
variabl
link
test
estim
pearson
correl
coeffi
cient
valu
mass
cluster
correspond
class
label
across
train
set
use
estim
rank
posit
neg
correl
mass
cluster
select
ten
mass
cluster
highest
posit
ten
highest
neg
correl
coeffi
cient
use
chunk
decomposit
implement
support
vector
machin
svm
light
use
waikato
environ
knowledg
analysi
decis
tree
algorithm
boost
mlp
experiment
framework
code
matlab
java
custom
reusabl
objectori
databas
creat
use
objectdb
interfac
experiment
framework
matlab
interfac
svm
light
obtain
onlin
spider
matlab
objectori
machin
learn
librari
obtain
onlin
modifi
ed
use
svm
light
version
sponsor
studi
direct
role
studi
design
data
collect
data
analysi
data
interpret
write
report
proport
serum
sampl
patient
tuberculosi
made
avail
tb
databank
correspond
author
full
access
data
studi
fi
nal
respons
decis
submit
public
detail
patient
control
fi
rst
phase
studi
given
tabl
patient
advanc
pulmonari
diseas
present
cough
fever
weight
loss
major
smear
posit
cavitari
diseas
gener
diagnost
classifi
er
tuberculosi
fi
rst
profi
led
serum
sampl
weak
cation
exchang
protein
chip
array
selditof
ms
identifi
ed
peak
cluster
mz
spectra
rang
choic
chip
surfac
base
previou
observ
surfacechemistri
yield
particularli
rich
spectra
serum
spectra
assign
randomli
train
test
set
use
supervis
machin
learn
classifi
cation
method
tabl
webappendix
discrimin
proteom
spectra
patient
tuberculosi
control
use
train
test
set
approach
tabl
abil
classifi
er
discrimin
data
correctli
test
set
known
generalis
perform
compar
generalis
perform
rang
classifi
er
plot
perform
test
set
roc
space
fi
gure
gaussian
kernel
svm
tabl
fi
gure
red
squar
best
discrimin
tuberculosi
control
group
sensit
specifi
citi
overal
accuraci
svm
classifi
er
defi
ne
convex
hull
roc
space
fi
gure
red
line
achiev
best
accuraci
sampl
fi
patient
tuberculosi
four
control
test
set
misclassifi
ed
webtabl
notabl
control
patient
respiratori
infect
test
set
correctli
classifi
ed
svm
seven
patient
sarcoidosi
none
african
control
patient
sleep
sick
malaria
misclassifi
ed
one
smearneg
case
tuberculosi
miss
appli
test
generalis
perform
svm
tenfold
crossvalid
entir
set
spectra
train
test
obtain
accuraci
sd
sensit
specifi
citi
optimis
accuraci
fi
gure
also
evalu
generalis
perform
svm
rerandomis
alloc
spectra
new
train
test
set
vari
proport
train
test
case
set
obtain
valu
accuraci
sensit
specifi
citi
exceed
data
shown
robust
svm
confi
rmed
mean
perform
randomli
gener
set
shown
roc
curv
fi
gure
webfi
gure
area
curv
coeffi
cient
variat
peak
intens
spectra
deriv
singl
sampl
run
time
six
assay
intraassay
interassay
data
obtain
averag
valu
nine
highest
amplitud
peak
follow
mz
valu
measur
reproduc
univers
control
spectra
run
diff
erent
time
period
correctli
classifi
ed
control
svm
classifi
er
obtain
tenfold
crossvalid
select
subset
inform
peak
cluster
evalu
appli
correl
fi
lter
method
detect
independ
inform
peak
rank
ten
mass
cluster
highest
posit
ten
highest
neg
pearson
correl
coeffi
cient
studi
discriminatori
power
select
mass
cluster
fi
rst
pair
mass
everi
pair
train
svm
classifi
er
diagnos
tuberculosi
case
rank
generalis
perform
accuraci
show
pair
select
mass
cluster
gave
accuraci
greater
combin
neg
posit
correl
mass
cluster
webfi
gure
mass
cluster
pair
achiev
sensit
greater
specifi
citi
greater
adaboostadapt
boost
slpsingl
layer
perceptron
mlpmulti
layer
perceptron
hlhidden
layer
nneuron
see
onlin
webtabl
webfi
gure
confi
rming
better
generalis
reli
combin
two
mass
peak
second
svm
train
correlationselect
mass
cluster
achiev
accuraci
independ
test
set
indic
cluster
contain
relev
discriminatori
inform
inform
remain
peak
cluster
retain
inferior
though
accept
diagnost
accuraci
fi
gure
indic
substanti
residu
diagnost
inform
remain
peak
cluster
summaris
generalis
perform
svm
roc
space
diff
erent
set
mass
cluster
fi
gure
webtabl
roc
convex
hull
fi
gure
red
line
defi
ned
two
classifi
er
fi
gure
red
squar
green
squar
highest
specifi
citi
red
squar
obtain
peak
minu
ten
posit
correl
total
confi
rming
inform
valu
neg
correl
peak
optim
classifi
er
fi
gure
green
squar
obtain
use
ten
posit
ten
neg
correl
subset
mass
cluster
use
highresolut
massspectrometri
tryptic
digest
identifi
ed
kda
posit
protein
marker
deriv
serum
amyloid
kda
neg
protein
marker
deriv
transthyretin
webfi
gure
molecular
weight
observ
mass
spectrum
kda
protein
identifi
ed
transthyretin
correspond
close
theoret
valu
kda
protein
howev
observ
serum
amyloid
kda
da
lower
theoret
valu
kda
suggest
protein
variant
serum
amyloid
investig
natur
variant
tryptic
digest
analys
detail
found
includ
peptid
mz
correspond
tryptic
peptid
predict
full
amino
acid
sequenc
serum
amyloid
howev
correspond
peptid
sffsflgeafdgar
would
result
loss
ntermin
arginin
translat
proteom
signatur
convent
test
format
measur
serum
amyloid
transthyretin
immunoassay
patient
serum
also
measur
creactiv
protein
neopterin
previous
use
monitor
diseas
activ
tuberculosi
select
best
polynomi
gaussian
kernel
svm
paramet
four
marker
best
classifi
er
obtain
gaussian
svm
fi
gure
svm
classifi
er
train
transthyretin
creactiv
protein
neopterin
valu
discrimin
patient
tuberculosi
control
accuraci
sensit
specifi
citi
fi
gure
black
triangl
optimis
classifi
er
serum
amyloid
creactiv
protein
transthyretin
fi
gure
purpl
triangl
webtabl
creactiv
protein
neopterin
serum
amyloid
fi
gure
green
triangl
webtabl
confi
rm
fi
nding
subsequ
appli
classifi
er
second
independ
test
set
obtain
prospect
collect
serum
sampl
patient
attend
two
uk
hospit
case
control
care
match
ethnic
origin
rigor
standardis
protocol
follow
sampl
collect
process
patient
tuberculosi
pulmonari
diseas
major
control
respiratori
ill
project
normalis
random
present
tree
winnow
tree
without
adaboost
project
normalis
project
normalis
red
line
indic
convex
hull
b
gaussian
kernel
support
vector
machin
perform
tenfold
crossvalid
block
three
bar
show
valu
accuraci
red
sensit
green
specifi
citi
blue
obtain
sigma
gaussiankernel
optimis
criteria
c
averag
roc
use
tenfold
train
crossvalid
test
randomli
select
train
test
set
train
test
ratio
paramet
select
tenfold
crossvalid
train
set
perform
obtain
test
red
line
show
averag
roc
curv
classifi
er
obtain
kernel
paramet
select
accuraci
criteria
similar
roc
curv
obtain
select
sensit
specifi
citi
webfi
gure
see
onlin
webfi
gure
webtabl
data
classifi
er
train
spectra
obtain
fi
rst
phase
studi
discrimin
case
tuberculosi
control
complet
new
dataset
sensit
specifi
citi
webtabl
moreov
classifi
er
train
mass
cluster
highlight
correl
analysi
achiev
sensit
specifi
citi
combin
four
immunoquantit
biomark
achiev
accuraci
sensit
specifi
citi
web
tabl
investig
new
approach
diagnos
tuberculosi
use
serum
patient
diseas
control
sever
countri
repres
least
four
diff
erent
ethnic
background
despit
heterogen
control
group
svm
diagnost
classifi
er
discrimin
accur
patient
tuberculosi
smearneg
smearposit
infect
noninfect
infl
ammatori
condit
result
provid
proofofprincipl
diagnost
approach
base
proteom
signatur
appli
tuberculosi
classifi
er
retain
similar
diagnost
perform
valid
popul
african
tuberculosi
clinic
preval
tuberculosi
patient
present
respiratori
symptom
might
around
posit
neg
predict
valu
best
classifi
er
would
respect
diagnost
accuraci
would
surpass
avail
immedi
diagnost
option
could
yield
result
much
rapidli
cultur
howev
although
seldi
technolog
provid
diagnost
test
tuberculosi
make
previou
assumpt
ident
protein
constitut
inform
signatur
cost
complex
preclud
gener
use
therefor
identifi
ed
two
discriminatori
protein
demonstr
possibl
implement
convent
diagnost
assay
adapt
fi
eld
use
protein
serum
amyloid
transthyretin
select
pearson
correl
analysi
confi
rmed
svm
classifi
cation
proteom
signatur
alreadi
independ
associ
pathophysiolog
process
tuberculosi
serum
amyloid
acut
phase
protein
associ
circul
highdens
lipoprotein
modul
lipid
traffi
cking
immun
respons
precursor
protein
reactiv
amyloidosi
complic
chronic
tuberculosi
individu
marker
diseas
activ
sever
infl
ammatori
state
includ
tuberculosi
elisa
assay
use
commerci
avail
antibodi
recognis
total
serum
amyloid
rather
desarginin
subtyp
identifi
ed
signatur
specifi
c
detect
variant
might
enhanc
diagnost
discrimin
transthyretin
kda
homotetram
serum
major
transport
thyroxin
triiodothyronin
well
vitamin
retinol
transretino
acid
associ
retinolbind
protein
retino
acid
stimul
monocyt
diff
erenti
inhibit
multipl
tuberculosi
human
macrophag
low
level
vitamin
correl
reduc
transthyretin
rais
concentr
creactiv
protein
report
patient
tuberculosi
truncat
form
transthyretin
neg
marker
proteom
fi
ngerprint
studi
ovarian
cancer
serum
amyloid
posit
marker
sever
acut
respiratori
syndrom
sar
indic
relaps
nasopharyng
cancer
artefact
associ
collect
handl
sampl
spectrum
gener
could
creat
spuriou
classifi
cation
although
collect
bias
diffi
cult
control
also
use
archiv
sampl
sought
minimis
postcollect
bia
interspers
process
sampl
case
control
month
use
sampl
four
geograph
site
vari
hiv
serostatu
anoth
possibl
sourc
bia
predomin
african
patient
tuberculosi
group
white
peopl
control
howev
least
control
subsaharan
african
origin
possibl
although
unlik
classifi
er
detect
presenc
tuberculosi
infect
rather
activ
diseas
tuberculin
skintest
reactiv
question
marker
latent
tuberculosi
avail
control
patient
substanti
minor
african
asian
control
patient
probabl
latent
infect
moreov
eff
ectiv
classifi
er
basi
four
biomark
three
infl
ammatori
marker
provid
evid
discrimin
group
basi
quiescent
tuberculosi
notabl
fi
patient
tuberculosi
misclassifi
ed
svm
three
ugandan
wherea
four
misclassifi
ed
control
two
white
divers
patholog
control
group
also
like
made
correct
classifi
cation
diffi
cult
furthermor
fi
nding
unlik
bias
systemat
diff
erenc
concurr
drug
treatment
patient
tuberculosi
start
chemotherapi
time
recruit
nevertheless
bias
could
introduc
predomin
archiv
sampl
tuberculosi
group
collect
africa
deriv
databank
compar
control
set
therefor
appli
train
classifi
er
second
independ
dataset
collect
prospect
later
date
uk
month
patient
dataset
close
match
ethnic
origin
includ
greater
proport
control
respiratori
diseas
train
set
sampl
test
set
process
precis
standard
oper
protocol
fact
diagnost
perform
classifi
er
surviv
rigor
test
new
set
strengthen
conclus
fi
rst
part
studi
small
decreas
diagnost
accuraci
might
least
partli
attribut
small
size
second
dataset
might
also
refl
ect
exist
bias
fi
rst
dataset
limit
selditof
platform
respect
reproduc
peak
intens
might
also
eff
ect
exampl
although
found
averag
interassay
coeffi
cient
variat
nine
univers
present
peak
qualiti
control
spectra
may
larger
variat
low
intens
peak
resid
closer
nois
suggest
consist
mainten
greater
diagnost
accuraci
across
two
dataset
seen
inher
less
variabl
immunolog
assay
strengthen
diagnost
approach
use
two
independ
assay
key
advantag
selditof
ms
lie
discoveri
phase
profi
le
larg
number
sampl
high
throughput
fashion
use
whole
signatur
reduc
problem
individu
variabl
peak
detect
although
singl
protein
marker
might
insuffi
cient
accuraci
diagnosi
tuberculosi
use
proteomeguid
analysi
combin
machin
learn
method
svm
achiev
better
accuraci
current
standard
method
fi
nding
suggest
marker
low
individu
diagnost
specifi
citi
boost
diagnost
yield
use
particular
combin
case
truncat
fragment
deriv
common
plasma
protein
might
specifi
c
marker
diseas
aris
proteolyt
enzym
induct
characterist
defi
ned
diseas
state
exampl
desarginin
variant
serum
amyloid
identifi
ed
might
specifi
c
variant
tuberculosi
similarli
truncat
form
anoth
appar
nonspecifi
c
acutephas
protein
report
rel
specifi
c
marker
sar
thu
possibl
explan
appar
paradox
seemingli
nonspecifi
c
acutephas
protein
could
provid
diagnost
specifi
citi
particular
infect
possibl
diseasespecifi
c
modifi
cation
common
protein
propos
sever
cancer
preserv
high
diagnost
accuraci
translat
proteom
signatur
immunoassay
plausibl
diseaseassoci
identifi
ed
biomark
establish
valu
svm
classifi
er
diagnosi
tuberculosi
provid
strong
evid
support
use
serolog
test
although
shown
reason
diagnost
accuraci
base
subset
four
biomark
illustr
principl
better
classifi
er
might
ultim
requir
use
larger
number
biomark
adapt
test
fi
eld
use
antibodi
panel
defi
ned
biomark
could
incorpor
dipsticktyp
format
pattern
analys
train
svm
classifi
er
person
comput
test
appli
longitudin
studi
tuberculosi
diffi
cult
diagnost
categori
sputumneg
tuberculosi
extrapulmonari
case
paediatr
infect
studi
design
agranoff
fernandezrey
krishna
fernandezrey
herbster
develop
machinelearn
featur
select
analys
fernandezrey
roja
classifi
cation
experi
produc
diagnost
svm
classifi
er
loosemor
r
pollock
c
rayner
recruit
patient
obtain
serum
sampl
uk
schwenk
provid
uk
tuberculosi
serum
sampl
agranoff
papadopoulo
fernandezrey
e
tarelli
gener
mass
spectra
protein
identifi
cation
undertaken
agranoff
help
e
tarelli
j
sheldon
coordin
advis
immunoassay
write
agranoff
fernandezrey
krishna
contribut
author
agranoff
fernandezrey
contribut
equal
work
st
georg
univers
london
appli
patent
diagnos
tuberculosi
